Seven Years of Blood Sugar Management with GlucAffect
This November marks the 7th anniversary of Reliv’s GlucAffect® nutritional supplement launch. GlucAffect was developed to support healthy blood sugar levels and weight loss, indicators of metabolic syndrome which can lead to chronic diseases, such as diabetes and cardiovascular disease. Research supports the effectiveness of the GlucAffect formulation.
GlucAffect was studied in an 8-week clinical trial that included 50 overweight participants with moderately elevated fasting blood glucose. Subjects were randomly assigned to either four daily servings of GlucAffect or a placebo meal replacement, and all participants took part in a diet and exercise program. Those who took GlucAffect lowered their fasting glucose by an average of 30%, moving them to healthy blood glucose levels. They also lost an average of 16 pounds. The control group taking the placebo did not experience significant reduction in their blood glucose levels or weight.
The patented GlucAffect formula includes several potent extracts, such as Pycnogenol®, LunaRich® and banaba leaf, which continue to be studied for their health benefits, especially in regards to the risk factors of metabolic syndrome.
Pycnogenol – a powerful antioxidant that has been shown to lower blood glucose levels, LDL and blood pressure.
A 2015 review in Phytotherapy Research reported that Pycnogenol’s “strong antioxidant, anti-inflammatory, endothelium-dependent vasodilator activity, and also its anti-thrombotic effects make it appropriate for targeting the multifaceted pathophysiology of metabolic syndrome. Clinical studies have shown that it can reduce blood glucose levels in people with diabetes, blood pressure in mild to moderate hypertensive patients and waist circumference; and improve lipid profile, renal and endothelial functions in metabolic syndrome.” Continue reading “Science & Health Today: Blood Sugar Management”